SHANNON JOHNSTON: Open Payments
NPI 1427544089 · LOW MOOR, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 45 payments from 14 companies in 2025. Trend: 2023 $542 · 2024 $957 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Lilly USA, LLC | 5 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $48 |
| Amgen Inc. | 3 | $46 |
| Exact Sciences Corporation | 2 | $38 |
| Ascendis Pharma Endocrinology Inc | 2 | $33 |
| PFIZER INC. | 2 | $29 |
Products named: VRAYLAR, REXULTI, MOUNJARO, BREZTRI, XIFAXAN, QULIPTA, OTEZLA, The Cologuard Plus Collection Kit.
Industry payments across VA — which companies pay providers there.
